📜 What This Document Is 📜

This filing is an 8-K, which is a type of report submitted to the SEC (Securities and Exchange Commission). Think of it as a mandatory "current report" that allows Oscar Health to immediately tell the market about material events that have happened or are about to happen. Since the company is announcing future guidance and board changes, filing this report ensures all investors and the public receive this key information at once.

👉 This document is a snapshot of very recent and important company news, not a full financial statement, so readers should look closely at the dates and the confirmed financial guidance.

🏢 What The Company Does 🏥

Oscar Health, Inc. is a healthcare company that operates in the insurance space. While the filing doesn't detail their exact product line, it confirms they are structured as a provider of health insurance and Health Maintenance Organization (HMO) services. These services involve managing the financial risk and care coordination for their members.

👉 Understanding that they are a health insurer means their financial performance is heavily tied to changing healthcare regulations and consumer health trends.

💰 Guidance Reaffirmation for 2026 📈

The most critical piece of information in this filing is the reaffirmation of the full year 2026 financial guidance. When a company "reaffirms" guidance, it means they are confirming that their previous financial predictions are still accurate and they do not expect any significant changes to those forecasts.

• The Company is reaffirming the full year 2026 guidance that was initially released on February 10, 2026, during their Q4 and full year 2025 financial results press release.
• This reaffirms their strategic outlook for the entire year, giving investors confidence that the core business assumptions remain sound.

👉 The market will pay close attention to these guidance figures because they set the expectation for profitability and growth for the entire fiscal year.

📅 Upcoming Milestones & Dates 🚀

The filing provides three key upcoming dates that investors need to mark on their calendars. These dates define the immediate financial timetable for the company and its leadership.

• Medicarians 2026 Conference: Oscar Health will participate in this conference on April 21, 2026. This is where they delivered their current guidance reaffirmation.
• Q1 2026 Results: The financial results for the first quarter of 2026 are expected to be released before the market opens on Wednesday, May 6, 2026.
• Earnings Call: A dedicated conference call to review the Q1 2026 results will be held at 8:00 AM ET on May 6, 2026.

👉 Missing these dates could mean missing critical updates on the company's immediate financial health.

👥 Board Leadership Updates 🧑‍💼

Oscar Health announced upcoming changes regarding its Board leadership on April 21, 2026. This indicates a planned restructuring of the group's governance and oversight structure. The details of these changes are furnished in Exhibit 99.1, which is incorporated into the current report.

👉 Changes in board leadership often signal a strategic pivot or a shift in corporate priorities, and the specifics in Exhibit 99.1 would provide deeper context for investors.

🚨 Potential Risks and Cautionary Notes ⚠️

Because the healthcare and technology industries are inherently complex, the company provides a lengthy list of risk factors. This is standard practice and is designed to warn investors about potential negative events that could impact the company's performance.

• Technological & Operational Risks: The company faces risks associated with data security breaches, and uncertainties related to its use of artificial intelligence and machine learning models.
• Market & Regulatory Risks: Risks include heightened competition, the potential for unfavorable or costly outcomes of lawsuits, and the fact that they are subject to extensive and complex laws and regulations.
• Corporate Structure Risks: The filing specifically mentions adverse consequences related to their "dual class structure" or "controlled company" status, which is a key governance concern for some investors.

👉 These risks are critical to understand because they represent external challenges and operational weaknesses that could override positive financial results.

📞 General Company Information 🗺️

For general inquiries, the company listed its physical and operational contact details.

• Address: 75 Varick Street, 5th Floor, New York, NY 10013.
• Telephone: (646) 403-3677.

👉 This establishes the official mailing and contact point for the corporation as of April 2026.

---

🧠 The Analogy

Think of the company’s financial guidance like a GPS route plan: when Oscar Health reaffirmed the full year 2026 guidance, they were essentially saying, "Despite any small traffic jams we hit this quarter, our destination and expected arrival time for the end of the year have not changed." It gives clarity and stability to the market, but the list of risks is like looking at potential road closures—they are warnings that could force them to take an entirely different route than planned.

🧩 Final Takeaway

Oscar Health reaffirmed its 2026 financial guidance and announced a restructuring of its board leadership. The next key focus for the market will be the Q1 2026 earnings call on May 6, 2026, where they will provide the most current picture of operational momentum.